Fulgence Niyibitegeka Receives Prestigious International Robert Austrian Research Award in Pneumococcal Vaccinology

Fulgence Niyibitegeka from the Economics of Global Health and Infectious Diseases Unit at Melbourne Health Economics has been awarded a 2026 Robert Austrian Research Award by the International Society of Pneumonia and Pneumococcal Diseases (ISPPD).

The Robert Austrian Research Award is the most prestigious international award in pneumococcal research for early-career researchers offered by ISPPD. It recognises emerging researchers making outstanding contributions to pneumococcal disease research and prevention globally. The award supports innovative research aimed at strengthening evidence to inform pneumococcal vaccination policy and improve public health outcomes.

Fulgence received the award for his proposed research on optimising pneumococcal conjugate vaccine (PCV) delivery strategies in low- and middle-income countries. His project focuses on developing a practical economic and budget optimisation tool to help countries evaluate more affordable and sustainable PCV strategies under increasingly constrained immunisation financing environments.

The project will explore policy options such as lower-cost PCV products, reduced-dose schedules, and fractional dosing strategies, with the aim of supporting evidence-informed decisions that maintain disease control while improving the long-term financial sustainability of immunisation programs. The project is particularly timely given the current context of shrinking global health funding, which is increasing pressure on countries to identify more efficient and sustainable approaches to financing immunisation programs. The research will be conducted under the supervision of Associate Professor Natalie Carvalho and Professor Fiona Russell.

The award was announced during the 14th Meeting of ISPPD, held from 17-21 May 2026 in Copenhagen.